Breaking News Instant updates and real-time market news.

DBX

Dropbox

$34.08

2.54 (8.05%)

14:49
08/09/18
08/09
14:49
08/09/18
14:49

Dropbox options imply 15.3% move in share price post-earnings, above median historical move

Pre-earnings options volume in Dropbox is 5.5x normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 15.3%, or $5.21, after results are released. Median move over the past eight quarters is 2.2%.

  • 09

    Aug

  • 04

    Sep

DBX Dropbox
$34.08

2.54 (8.05%)

05/11/18
ADAM
05/11/18
NO CHANGE
Target $36
ADAM
Buy
Dropbox weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Davis noted Dropbox shares sold off following its Q1 earnings release but he said he would be an "aggressive buyer" of the shares using the weakness as a buying opportunity. He noted the company delivered upside on every metric and made progress on customer additions, ARPU, and product innovation. Davis reiterated his Buy rating and raised his price target to $36 from $35 on Dropbox shares.
05/17/18
DBAB
05/17/18
NO CHANGE
DBAB
Buy
Google changes unlikely to impact Dropbox, says Deutsche Bank
Dropbox (DBX) rival Google (GOOG, GOOGL) this week announced some changes to its consumer-based cloud storage service, Deutsche Bank analyst Karl Keirstead tells investors in a research note. The analyst notes that Google is moving all paid Google Drive consumer subscribers to a newly named Google One service, which includes added storage capacity options, "expert assistance" and the ability to add family members. Google also cut the price of its 2TB capacity plan in half, to $10 from $20 per month, Keirstead adds. He does not see these changes materially impacting Dropbox and keeps a Buy rating on the shares.
08/01/18
JEFF
08/01/18
UPGRADE
Target $32
JEFF
Buy
Dropbox upgraded to Buy from Hold at Jefferies
Jefferies analyst John DiFucci upgraded Dropbox to Buy with an unchanged price target of $32. The analyst is not making a call on the Q2 results, which come on August 9. Rather, the upgrade is based "entirely on valuation." The stock is down 16% over the past week "on no material change," DiFucci tells investors in a research note. He continues to view Dropbox's "attractive, sustainable model as unique in software."
08/01/18
08/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPGRADES DROPBOX TO BUY: Jefferies analyst John DiFucci upgraded Dropbox (DBX) to Buy from Hold with an unchanged price target of $32. The analyst is not making a call on the Q2 results, which come on August 9. Rather, the upgrade is based "entirely on valuation," he stated. Dropbox is up 4.7% in late morning trading. JEFFERIES UPGRADES PAPA JOHN'S: Jefferies analyst Alexander Slagle upgraded Papa John's (PZZA) to Buy from Hold and raised his price target for the shares to $58 from $52. The stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving, Slagle said. After reviewing the company's potential path to recovery and possible strategic actions that could create shareholder value, the analyst has a bull case of $75 per share. He thinks this outweighs the bear case, or downside risk, of $35 per share. SAREPTA UPGRADED AFTER PULLBACK: Morgan Stanley analyst Matthew Harrison upgraded Sarepta Therapeutics (SRPT) to Overweight from Equal Weight, noting that the stock has given up much of the gains it saw when its initial DMD gene therapy data was announced. He sees the pullback as an opportunity to own the stock near pre-DMD gene therapy levels without taking the binary risk. He doesn't think a major bear case has emerged on the prospects for the company's DMD gene therapy program and he sees major catalysts in the second half of this year that he believes the market is missing. Harrison has a $163 price target on Sarepta shares. PIPER CUTS SHOPIFY TO NEUTRAL: Piper Jaffray analyst Michael Olson downgraded Shopify (SHOP) to Neutral from Overweight and lowered his price target to $145 from $155, saying that Shopify's Q2 was "good, but not good enough" with monthly recurring revenue below investor expectations. While Olson said Shopify is performing well, he believes their performance is mostly reflected in the stock's current valuation. PIPER RECOMMENDS BIOGEN AFTER MANAGEMENT MEETING: After hosting investor meetings with Biogen (BIIB) investor relations this week, Piper Jaffray analyst Christopher Raymond came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond said. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on Biogen. He kept an Overweight rating on shares with a $400 price target.

TODAY'S FREE FLY STORIES

IO

ION Geophysical

$16.65

0.05 (0.30%)

15:58
08/20/18
08/20
15:58
08/20/18
15:58
Hot Stocks
Breaking Hot Stocks news story on ION Geophysical »

Rajay Bagaria reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTX

Centex

$25.26

1.92 (8.23%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Centex 

Qwest trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story  

Qwest trading resumes

PAY

Verifone

$23.04

(0.00%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Verifone 

Verifone trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTU

Chad Therapeutics, Inc.

$25.26

1.925 (8.25%)

15:57
08/20/18
08/20
15:57
08/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Chad Therapeutics, Inc. 

Qwest trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$44.80

-0.44 (-0.97%)

, EIX

Edison International

$69.24

-0.62 (-0.89%)

15:56
08/20/18
08/20
15:56
08/20/18
15:56
Periodicals
California plan could let PG&E issue bonds to cover fire damages, Bloomberg says »

California Senator Bill…

PCG

PG&E

$44.80

-0.44 (-0.97%)

EIX

Edison International

$69.24

-0.62 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPY

Brookfield Property

$19.90

-0.19 (-0.95%)

15:55
08/20/18
08/20
15:55
08/20/18
15:55
Options
Brookfield Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

VERI

Veritone

$11.25

-0.16 (-1.40%)

15:55
08/20/18
08/20
15:55
08/20/18
15:55
Conference/Events
Veritone to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

CBS

CBS

$53.67

0.45 (0.85%)

15:46
08/20/18
08/20
15:46
08/20/18
15:46
Periodicals
Court revives copyright suit against CBS over pre-1972 recordings, Reuters says »

CBS is facing a lawsuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 27

    Sep

TSLA

Tesla

$304.35

-0.98 (-0.32%)

15:42
08/20/18
08/20
15:42
08/20/18
15:42
Periodicals
Some Tesla suppliers worry about getting paid, WSJ reports »

Some Tesla suppliers have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

FIT

Fitbit

$6.02

0.315 (5.52%)

15:37
08/20/18
08/20
15:37
08/20/18
15:37
Hot Stocks
Fitbit announces Fitbit Charge 3 »

Earlier today, Fitbit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

NDSN

Nordson

$134.72

-0.07 (-0.05%)

15:34
08/20/18
08/20
15:34
08/20/18
15:34
Options
Nordson options imply 7.8% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

GOOG

Alphabet

$1,207.00

7.21 (0.60%)

, GOOGL

Alphabet Class A

$1,222.10

6.6 (0.54%)

15:31
08/20/18
08/20
15:31
08/20/18
15:31
Periodicals
Google, IMAX VR project quietly canceled, Variety reports »

A joint virtual reality…

GOOG

Alphabet

$1,207.00

7.21 (0.60%)

GOOGL

Alphabet Class A

$1,222.10

6.6 (0.54%)

IMAX

Imax

$22.80

0.4 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 06

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

STAA

STAAR Surgical

$42.05

1.1 (2.69%)

15:24
08/20/18
08/20
15:24
08/20/18
15:24
Conference/Events
STAAR Surgical management to meet with William Blair »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

SRI

Stoneridge

$32.61

0.39 (1.21%)

15:23
08/20/18
08/20
15:23
08/20/18
15:23
Hot Stocks
Stoneridge appoints Laurent Borne as Chief Technology Officer »

Stoneridge announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 29

    Oct

  • 06

    Nov

DVA

DaVita

$72.44

-0.05 (-0.07%)

15:22
08/20/18
08/20
15:22
08/20/18
15:22
Conference/Events
DaVita management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ALTR

Altair

$40.63

0.4 (0.99%)

15:20
08/20/18
08/20
15:20
08/20/18
15:20
Conference/Events
Altair management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 12

    Sep

CBOE

Cboe Global Markets

$98.72

2.96 (3.09%)

15:20
08/20/18
08/20
15:20
08/20/18
15:20
Options
Sweep buyer of CBOE calls »

Sweep buyer of CBOE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANH

Fanhua

$25.76

0.53 (2.10%)

15:19
08/20/18
08/20
15:19
08/20/18
15:19
Options
Fanhua options imply 7.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/20/18
08/20
15:17
08/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/20/18
08/20
15:16
08/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRAY

Dentsply Sirona

$38.84

0.17 (0.44%)

15:12
08/20/18
08/20
15:12
08/20/18
15:12
Conference/Events
Dentsply Sirona management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Sep

  • 06

    Nov

STZ

Constellation Brands, also tag STZ.B

$202.74

-1.16 (-0.57%)

15:11
08/20/18
08/20
15:11
08/20/18
15:11
Options
Repeat call spreads in Constellation Brands »

Repeat call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

LCI

Lannett

$5.43

-8.075 (-59.81%)

, AMRX

Amneal Pharmaceuticals

$23.86

2.33 (10.82%)

15:08
08/20/18
08/20
15:08
08/20/18
15:08
Recommendations
Lannett, Amneal Pharmaceuticals analyst commentary  »

Lannett price target…

LCI

Lannett

$5.43

-8.075 (-59.81%)

AMRX

Amneal Pharmaceuticals

$23.86

2.33 (10.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

  • 05

    Sep

  • 12

    Sep

15:05
08/20/18
08/20
15:05
08/20/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.